{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:34:44Z","timestamp":1791214484090,"version":"4.1.0"},"reference-count":215,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,9,3]],"date-time":"2014-09-03T00:00:00Z","timestamp":1409702400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["epilepsybehavior.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy &amp; Behavior"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.yebeh.2014.08.134","type":"journal-article","created":{"date-parts":[[2014,11,5]],"date-time":"2014-11-05T02:33:50Z","timestamp":1415154830000},"page":"147-157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":92,"special_numbering":"C","title":["Metabolic and mitochondrial disorders associated with epilepsy in children with autism spectrum disorder"],"prefix":"10.1016","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4442-2937","authenticated-orcid":false,"given":"Richard E.","family":"Frye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2014.08.134_bb0005","series-title":"Diagnostic and statistical manual of mental disorders","author":"APA","year":"1994"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0010","first-page":"1","volume":"63","year":"2014","journal-title":"MMWR Surveill Summ"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0015","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1007\/s10803-013-1973-x","article-title":"Gastrointestinal problems in children with autism, developmental delays or typical development","volume":"44","author":"Chaidez","year":"2013","journal-title":"J Autism Dev Disord"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0020","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3389\/fpubh.2013.00031","article-title":"A review of traditional and novel treatments for seizures in autism spectrum disorder: findings from a systematic review and expert panel","volume":"1","author":"Frye","year":"2013","journal-title":"Front Public Health"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0025","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s12402-012-0086-2","article-title":"ADHD and autism: differential diagnosis or overlapping traits? A selective review","volume":"4","author":"Taurines","year":"2012","journal-title":"Atten Defic Hyperact Disord"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0030","doi-asserted-by":"crossref","first-page":"e1341","DOI":"10.1542\/peds.2013-1193","article-title":"Cognitive\u2013behavioral therapy for anxiety in children with high-functioning autism: a meta-analysis","volume":"132","author":"Sukhodolsky","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0035","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1007\/s10803-010-1171-z","article-title":"Brief report: \u201callergic symptoms\u201d in children with autism spectrum disorders. More than meets the eye?","volume":"41","author":"Angelidou","year":"2011","journal-title":"J Autism Dev Disord"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0040","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S1474-4422(02)00160-6","article-title":"Epilepsy in autism","volume":"1","author":"Tuchman","year":"2002","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0045","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1176\/ajp.136.10.1310","article-title":"The incidence of seizures among children with autistic symptoms","volume":"136","author":"Deykin","year":"1979","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0050","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00004583-199001000-00020","article-title":"Seizure disorders in autism","volume":"29","author":"Volkmar","year":"1990","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0055","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/j.1528-1167.2005.57504.x","article-title":"Epilepsy in young adults with autism: a prospective population-based follow-up study of 120 individuals diagnosed in childhood","volume":"46","author":"Danielsson","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0060","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.braindev.2006.12.012","article-title":"Autism and epilepsy: a retrospective follow-up study","volume":"29","author":"Hara","year":"2007","journal-title":"Brain Dev"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0065","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/j.1528-1167.2011.03069.x","article-title":"Medically refractory epilepsy in autism","volume":"52","author":"Sansa","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0070","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.yebeh.2012.11.002","article-title":"Epilepsy, autism, and neurodevelopment: kindling a shared vulnerability?","volume":"26","author":"Gilby","year":"2013","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0075","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/WCO.0b013e32835ee64f","article-title":"Autism and social cognition in epilepsy: implications for comprehensive epilepsy care","volume":"26","author":"Tuchman","year":"2013","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0080","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/mp.2011.165","article-title":"A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures","volume":"17","author":"Rossignol","year":"2012","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0085","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/gim.2013.32","article-title":"Clinical genetics evaluation in identifying the etiology of autism spectrum disorders: 2013 guideline revisions","volume":"15","author":"Schaefer","year":"2013","journal-title":"Genet Med"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0090","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1212\/WNL.0b013e3182a9f482","article-title":"NINDS epilepsy and autism spectrum disorders workshop report","volume":"81","author":"Tuchman","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0095","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.gde.2013.02.003","article-title":"Recent developments in the genetics of autism spectrum disorders","volume":"23","author":"Murdoch","year":"2013","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0100","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/mp.2011.175","article-title":"Cerebral folate receptor autoantibodies in autism spectrum disorder","volume":"18","author":"Frye","year":"2013","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0105","first-page":"263","article-title":"Folate receptor alpha autoimmunity and cerebral folate deficiency in autism spectrum disorders","volume":"2","author":"Rossignol","year":"2012","journal-title":"J Pediatr Biochem"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0110","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/ajmg.b.30368","article-title":"Abnormalities of cholesterol metabolism in autism spectrum disorders","volume":"141B","author":"Tierney","year":"2006","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0115","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1126\/science.1224631","article-title":"Mutations in BCKD-kinase lead to a potentially treatable form of autism with epilepsy","volume":"338","author":"Novarino","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0120","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s11910-009-0021-x","article-title":"Neurometabolic disorders and dysfunction in autism spectrum disorders","volume":"9","author":"Zecavati","year":"2009","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0125","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/mp.2010.136","article-title":"Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis","volume":"17","author":"Rossignol","year":"2012","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0130","doi-asserted-by":"crossref","first-page":"41R","DOI":"10.1203\/PDR.0b013e318212f16b","article-title":"Mitochondrial dysfunction can connect the diverse medical symptoms associated with autism spectrum disorders","volume":"69","author":"Frye","year":"2011","journal-title":"Pediatr Res"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0135","first-page":"181","article-title":"Metabolic disorders and abnormalities associated with autism spectrum disorder","volume":"2","author":"Frye","year":"2012","journal-title":"J Pediatr Biochem"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0140","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nrn3229","article-title":"Impaired mitochondrial function in psychiatric disorders","volume":"13","author":"Manji","year":"2012","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0145","doi-asserted-by":"crossref","first-page":"506","DOI":"10.4088\/JCP.11r07237","article-title":"The psychiatric manifestations of mitochondrial disorders: a case and review of the literature","volume":"73","author":"Anglin","year":"2012","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0150","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.braindev.2013.01.006","article-title":"Mitochondrial disease and epilepsy","volume":"35","author":"Kang","year":"2013","journal-title":"Brain Dev"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0155","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/00019052-200204000-00009","article-title":"The role of mitochondria in epileptogenesis","volume":"15","author":"Kunz","year":"2002","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0160","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.expneurol.2009.02.014","article-title":"Mitochondrial involvement in temporal lobe epilepsy","volume":"218","author":"Kudin","year":"2009","journal-title":"Exp Neurol"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0165","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.mito.2012.10.001","article-title":"Targeting the mitochondrial electron transport chain in autism, a systematic review and synthesis of a novel therapeutic approach","volume":"13","author":"Ghanizadeh","year":"2013","journal-title":"Mitochondrion"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0170","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s13311-013-0176-7","article-title":"Review of clinical trials for mitochondrial disorders: 1997\u20132012","volume":"10","author":"Kerr","year":"2013","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0175","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s10545-006-0212-4","article-title":"X-linked creatine transporter deficiency in two patients with severe mental retardation and autism","volume":"29","author":"Poo-Arguelles","year":"2006","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0180","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/ajmg.c.30292","article-title":"Disorders of creatine transport and metabolism","volume":"157C","author":"Longo","year":"2011","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0185","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1023\/A:1022443503883","article-title":"Creatine deficiency syndromes","volume":"244","author":"Schulze","year":"2003","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0190","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.ymgme.2011.11.191","article-title":"Treatable inborn errors of metabolism causing intellectual disability: a systematic literature review","volume":"105","author":"van Karnebeek","year":"2012","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0195","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s10545-006-0123-4","article-title":"X-linked creatine transporter defect: a report on two unrelated boys with a severe clinical phenotype","volume":"29","author":"Anselm","year":"2006","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0200","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1002\/ajmg.a.31294","article-title":"The near universal presence of autism spectrum disorders in children with Smith\u2013Lemli\u2013Opitz syndrome","volume":"140","author":"Sikora","year":"2006","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0205","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1176\/appi.ajp.2007.07020315","article-title":"Smith\u2013Lemli\u2013Opitz syndrome and autism spectrum disorder","volume":"164","author":"Bukelis","year":"2007","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0210","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/00004583-200105000-00008","article-title":"Smith\u2013Lemli\u2013Opitz syndrome","volume":"40","author":"Martin","year":"2001","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0215","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/(SICI)1096-8628(19970131)68:3<305::AID-AJMG11>3.0.CO;2-X","article-title":"Clinical effects of cholesterol supplementation in six patients with the Smith\u2013Lemli\u2013Opitz syndrome (SLOS)","volume":"68","author":"Elias","year":"1997","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0220","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/(SICI)1096-8628(19970131)68:3<311::AID-AJMG12>3.0.CO;2-W","article-title":"Treatment of Smith\u2013Lemli\u2013Opitz syndrome: results of a multicenter trial","volume":"68","author":"Irons","year":"1997","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0225","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/(SICI)1096-8628(19970131)68:3<315::AID-AJMG13>3.0.CO;2-W","article-title":"Cholesterol and bile acid replacement therapy in children and adults with Smith\u2013Lemli\u2013Opitz (SLO\/RSH) syndrome","volume":"68","author":"Nwokoro","year":"1997","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0230","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/09540260801889062","article-title":"Autism: the role of cholesterol in treatment","volume":"20","author":"Aneja","year":"2008","journal-title":"Int Rev Psychiatry"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0235","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/j.freeradbiomed.2012.03.011","article-title":"Oxidative stress-related biomarkers in autism: systematic review and meta-analyses","volume":"52","author":"Frustaci","year":"2012","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0240","first-page":"106","article-title":"Association of MTHFR gene variants with autism","volume":"9","author":"Boris","year":"2004","journal-title":"J Am Phys Surg"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0245","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/YPG.0b013e32832cebd2","article-title":"Aberrations in folate metabolic pathway and altered susceptibility to autism","volume":"19","author":"Mohammad","year":"2009","journal-title":"Psychiatr Genet"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0250","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1089\/gtmb.2012.0091","article-title":"Methylenetetrahydrofolate reductase polymorphisms C677T and risk of autism in the Chinese Han population","volume":"16","author":"Guo","year":"2012","journal-title":"Genet Test Mol Biomarkers"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0255","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3945\/ajcn.110.004416","article-title":"Maternal periconceptional folic acid intake and risk of autism spectrum disorders and developmental delay in the CHARGE (CHildhood Autism Risks from Genetics and Environment) case\u2013control study","volume":"96","author":"Schmidt","year":"2012","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0260","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1007\/s10803-010-1120-x","article-title":"Population- and family-based studies associate the MTHFR gene with idiopathic autism in simplex families","volume":"41","author":"Liu","year":"2011","journal-title":"J Autism Dev Disord"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0265","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/aur.70","article-title":"The MTHFR 677C\u2192T polymorphism and behaviors in children with autism: exploratory genotype\u2013phenotype correlations","volume":"2","author":"Goin-Kochel","year":"2009","journal-title":"Autism Res"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0270","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1111\/j.1582-4934.2008.00463.x","article-title":"One carbon metabolism disturbances and the C677T MTHFR gene polymorphism in children with autism spectrum disorders","volume":"13","author":"Pasca","year":"2009","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0275","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/ajmg.b.30366","article-title":"Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism","volume":"141B","author":"James","year":"2006","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0280","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/aur.1300","article-title":"Association between MTHFR gene polymorphisms and the risk of autism spectrum disorders: a meta-analysis","volume":"6","author":"Pu","year":"2013","journal-title":"Autism Res"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0285","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.neulet.2007.05.025","article-title":"Preliminary evidence for involvement of the folate gene polymorphism 19bp deletion-DHFR in occurrence of autism","volume":"422","author":"Adams","year":"2007","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0290","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1056\/NEJMoa043160","article-title":"Autoantibodies to folate receptors in the cerebral folate deficiency syndrome","volume":"352","author":"Ramaekers","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0295","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1055\/s-2008-1065354","article-title":"Folate receptor autoimmunity and cerebral folate deficiency in low-functioning autism with neurological deficits","volume":"38","author":"Ramaekers","year":"2007","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0300","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/j.1469-8749.2004.tb00451.x","article-title":"Cerebral folate deficiency","volume":"46","author":"Ramaekers","year":"2004","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0305","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1111\/j.1471-4159.2007.05095.x","article-title":"Characterization of folate uptake by choroid plexus epithelial cells in a rat primary culture model","volume":"104","author":"Wollack","year":"2008","journal-title":"J Neurochem"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0310","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/ana.410130620","article-title":"Kearns\u2013Sayre syndrome with reduced plasma and cerebrospinal fluid folate","volume":"13","author":"Allen","year":"1983","journal-title":"Ann Neurol"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0315","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/ana.20746","article-title":"Cerebral folate deficiency and leukoencephalopathy caused by a mitochondrial DNA deletion","volume":"59","author":"Pineda","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0320","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1055\/s-2007-991150","article-title":"Mitochondrial complex I encephalomyopathy and cerebral 5-methyltetrahydrofolate deficiency","volume":"38","author":"Ramaekers","year":"2007","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0325","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ymgme.2009.08.005","article-title":"Cerebral folate deficiency and CNS inflammatory markers in Alpers disease","volume":"99","author":"Hasselmann","year":"2010","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0330","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/archneurol.2011.80","article-title":"Cerebral folate deficiency syndromes in childhood: clinical, analytical, and etiologic aspects","volume":"68","author":"Perez-Duenas","year":"2011","journal-title":"Arch Neurol"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0335","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1212\/01.wnl.0000309223.98616.e4","article-title":"Mitochondrial diseases associated with cerebral folate deficiency","volume":"70","author":"Garcia-Cazorla","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0340","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1177\/0883073809342128","article-title":"Fever plus mitochondrial disease could be risk factors for autistic regression","volume":"25","author":"Shoffner","year":"2010","journal-title":"J Child Neurol"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0345","first-page":"427","article-title":"Autistic disorder with complex IV overactivity: a new mitochondrial syndrome","volume":"9","author":"Frye","year":"2011","journal-title":"J Pediatr Neurol"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0350","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/mp.2012.22","article-title":"Role of folate receptor autoantibodies in infantile autism","volume":"18","author":"Ramaekers","year":"2013","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0355","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1212\/01.WNL.0000154641.08211.B7","article-title":"Cerebral folate deficiency with developmental delay, autism, and response to folinic acid","volume":"64","author":"Moretti","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0360","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s00431-008-0823-x","article-title":"Clinical features and the management of pyridoxine-dependent and pyridoxine-responsive seizures: review of 63 North American cases submitted to a patient registry","volume":"168","author":"Basura","year":"2009","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0365","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1046\/j.1440-1754.2001.00701.x","article-title":"Pyridoxine-dependent seizures: a case report and a critical review of the literature","volume":"37","author":"Gupta","year":"2001","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0370","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nm1366","article-title":"Mutations in antiquitin in individuals with pyridoxine-dependent seizures","volume":"12","author":"Mills","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0375","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/humu.20433","article-title":"Biochemical and molecular characterization of 18 patients with pyridoxine-dependent epilepsy and mutations of the antiquitin (ALDH7A1) gene","volume":"28","author":"Plecko","year":"2007","journal-title":"Hum Mutat"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0380","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0887-8994(01)00407-6","article-title":"Pyridoxine-dependent seizures: findings from recent studies pose new questions","volume":"26","author":"Gospe","year":"2002","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0385","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S0140-6736(94)90236-4","article-title":"Reduced GABA synthesis in pyridoxine-dependent seizures","volume":"343","author":"Gospe","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0390","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1136\/adc.58.6.415","article-title":"Pyridoxine dependent seizures\u2014a wider clinical spectrum","volume":"58","author":"Bankier","year":"1983","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0395","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1542\/peds.90.2.221","article-title":"Postneonatal vitamin B6-dependent epilepsy","volume":"90","author":"Coker","year":"1992","journal-title":"Pediatrics"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0400","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/ana.410170203","article-title":"Atypical presentations of pyridoxine-dependent seizures: a treatable cause of intractable epilepsy in infants","volume":"17","author":"Goutieres","year":"1985","journal-title":"Ann Neurol"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0405","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/BF01958419","article-title":"Pyridoxine-dependent seizures, clinical and therapeutic aspects","volume":"150","author":"Haenggeli","year":"1991","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0410","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/ana.410130123","article-title":"Pyridoxine-dependency seizure: report of a rare presentation","volume":"13","author":"Krishnamoorthy","year":"1983","journal-title":"Ann Neurol"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0415","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0013-4694(91)90035-3","article-title":"Pyridoxine-dependent epilepsy: EEG investigations and long-term follow-up","volume":"78","author":"Mikati","year":"1991","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0420","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1136\/adc.81.5.431","article-title":"Epidemiology of pyridoxine dependent and pyridoxine responsive seizures in the UK","volume":"81","author":"Baxter","year":"1999","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0425","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/0006-3223(85)90019-8","article-title":"Vitamin B6, magnesium, and combined B6-Mg: therapeutic effects in childhood autism","volume":"20","author":"Martineau","year":"1985","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0430","first-page":"53","article-title":"Improvement of neurobehavioral disorders in children supplemented with magnesium-vitamin B6. II. Pervasive developmental disorder-autism","volume":"19","author":"Mousain-Bosc","year":"2006","journal-title":"Magnes Res"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0435","first-page":"27","article-title":"Clinical and biological effects of high doses of vitamin B6 and magnesium on autistic children","volume":"4","author":"Lelord","year":"1982","journal-title":"Acta Vitaminol Enzymol"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0440","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF01531686","article-title":"Effects of pyridoxine and magnesium on autistic symptoms\u2014initial observations","volume":"11","author":"Lelord","year":"1981","journal-title":"J Autism Dev Disord"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0445","first-page":"CD003497","article-title":"Combined vitamin B6\u2013magnesium treatment in autism spectrum disorder","author":"Nye","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0450","first-page":"213","article-title":"Novel and emerging treatments for autism spectrum disorders: a systematic review","volume":"21","author":"Rossignol","year":"2009","journal-title":"Ann Clin Psychiatry"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0455","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1177\/088307380001501111","article-title":"A 15-year follow-up of a boy with pyridoxine (vitamin B6)-dependent seizures with autism, breath holding, and severe mental retardation","volume":"15","author":"Burd","year":"2000","journal-title":"J Child Neurol"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0460","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1076\/chin.9.3.184.16457","article-title":"A case of partial biotinidase deficiency associated with autism","volume":"9","author":"Zaffanello","year":"2003","journal-title":"Child Neuropsychol"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0465","doi-asserted-by":"crossref","first-page":"7974","DOI":"10.1073\/pnas.1120210109","article-title":"A common X-linked inborn error of carnitine biosynthesis may be a risk factor for nondysmorphic autism","volume":"109","author":"Celestino-Soper","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0470","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s10803-004-5283-1","article-title":"Relative carnitine deficiency in autism","volume":"34","author":"Filipek","year":"2004","journal-title":"J Autism Dev Disord"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0475","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.bbabio.2010.04.018","article-title":"Mitochondrial dysfunction in autism spectrum disorders: cause or effect?","volume":"1797","author":"Palmieri","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0480","doi-asserted-by":"crossref","first-page":"e220","DOI":"10.1038\/tp.2012.143","article-title":"Unique acyl-carnitine profiles are potential biomarkers for acquired mitochondrial disease in autism spectrum disorder","volume":"3","author":"Frye","year":"2013","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0485","first-page":"23","article-title":"Short-chain fatty acid fermentation products of the gut microbiome: implications in autism spectrum disorders","author":"Macfabe","year":"2012","journal-title":"Microb Ecol Health Dis"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0490","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0009-8981(81)90184-4","article-title":"Urinary excretion of gamma-hydroxybutyric acid in a patient with neurological abnormalities. The probability of a new inborn error of metabolism","volume":"111","author":"Jakobs","year":"1981","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0495","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1212\/WNL.0b013e3181b163a5","article-title":"Decreased GABA-A binding on FMZ-PET in succinic semialdehyde dehydrogenase deficiency","volume":"73","author":"Pearl","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0500","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1017\/S1092852900016874","article-title":"Neuropsychiatric morbidity in adolescent and adult succinic semialdehyde dehydrogenase deficiency patients","volume":"13","author":"Knerr","year":"2008","journal-title":"CNS Spectr"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0505","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/00019052-200404000-00005","article-title":"Clinical aspects of the disorders of GABA metabolism in children","volume":"17","author":"Pearl","year":"2004","journal-title":"Curr Opin Neurol"},{"issue":"Suppl. 6","key":"10.1016\/j.yebeh.2014.08.134_bb0510","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1002\/ana.10629","article-title":"Succinic semialdehyde dehydrogenase deficiency in children and adults","volume":"54","author":"Pearl","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0515","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1212\/01.WNL.0000059549.70717.80","article-title":"Clinical spectrum of succinic semialdehyde dehydrogenase deficiency","volume":"60","author":"Pearl","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0520","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ymgme.2008.04.013","article-title":"Clinical, biochemical and molecular findings in seven Polish patients with adenylosuccinate lyase deficiency","volume":"94","author":"Jurecka","year":"2008","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0525","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ymgme.2006.04.018","article-title":"Adenylosuccinate lyase deficiency","volume":"89","author":"Spiegel","year":"2006","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0530","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/ejhg.2008.174","article-title":"Misleading behavioural phenotype with adenylosuccinate lyase deficiency","volume":"17","author":"Gitiaux","year":"2009","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0535","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1023\/A:1005563926383","article-title":"Metabolic approaches to the treatment of autism spectrum disorders","volume":"30","author":"Page","year":"2000","journal-title":"J Autism Dev Disord"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0540","doi-asserted-by":"crossref","first-page":"11601","DOI":"10.1073\/pnas.94.21.11601","article-title":"Developmental disorder associated with increased cellular nucleotidase activity","volume":"94","author":"Page","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0545","first-page":"31","article-title":"Phenylketonuria: an inborn error of phenylalanine metabolism","volume":"29","author":"Williams","year":"2008","journal-title":"Clin Biochem Rev"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0550","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1023\/A:1022999712639","article-title":"Autism and phenylketonuria","volume":"33","author":"Baieli","year":"2003","journal-title":"J Autism Dev Disord"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0555","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1111\/j.1528-1167.2007.01115.x","article-title":"Epilepsy in phenylketonuria: a complex dependence on serum phenylalanine levels","volume":"48","author":"Martynyuk","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0560","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1001\/archneur.1981.00510020080013","article-title":"EEG in phenylketonuria. Attempt to establish clinical importance of EEG changes","volume":"38","author":"Gross","year":"1981","journal-title":"Arch Neurol"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0565","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/2040-2392-4-16","article-title":"Decreased tryptophan metabolism in patients with autism spectrum disorders","volume":"4","author":"Boccuto","year":"2013","journal-title":"Mol Autism"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0570","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/pcn.12080","article-title":"Association of rs2129575 in the tryptophan hydroxylase 2 gene with clinical phenotypes of autism spectrum disorders","volume":"67","author":"Egawa","year":"2013","journal-title":"Psychiatry Clin Neurosci"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0575","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.neures.2012.05.012","article-title":"Association with tryptophan hydroxylase 2 gene polymorphisms and autism spectrum disorders in Korean families","volume":"73","author":"Yang","year":"2012","journal-title":"Neurosci Res"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0580","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.yebeh.2014.01.007","article-title":"Tryptophan hydroxylase 2 (TPH2) gene polymorphisms and psychiatric comorbidities in temporal lobe epilepsy","volume":"32","author":"Bragatti","year":"2014","journal-title":"Epilepsy Behav"},{"issue":"Suppl. 5","key":"10.1016\/j.yebeh.2014.08.134_bb0585","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1528-1167.2005.01008.x","article-title":"Reduced serotonin and 3-hydroxyanthranilic acid levels in serum of cystatin B-deficient mice, a model system for progressive myoclonus epilepsy","volume":"46","author":"Arbatova","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0590","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1111\/j.1528-1167.2006.00638.x","article-title":"Altered tryptophan metabolism in the brain of cystatin B-deficient mice: a model system for progressive myoclonus epilepsy","volume":"47","author":"Vaarmann","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0595","first-page":"133","article-title":"Autistic-like findings associated with a urea cycle disorder in a 4-year-old girl","volume":"30","author":"Gorker","year":"2005","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0600","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1177\/0883073809340696","article-title":"Neuropsychiatric manifestations in late-onset urea cycle disorder patients","volume":"25","author":"Serrano","year":"2010","journal-title":"J Child Neurol"},{"issue":"Suppl. 1","key":"10.1016\/j.yebeh.2014.08.134_bb0605","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.ymgme.2010.02.010","article-title":"Current concepts in the pathogenesis of urea cycle disorders","volume":"100","author":"Braissant","year":"2010","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0610","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/mp.2010.136","article-title":"Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis","volume":"17","author":"Rossignol","year":"2012","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0615","doi-asserted-by":"crossref","first-page":"141","DOI":"10.7156\/v5i3p141","article-title":"Biomarker of abnormal energy metabolism in children with autism spectrum disorder","volume":"5","author":"Frye","year":"2012","journal-title":"N Am J Med Sci"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0620","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1001\/jama.2010.1706","article-title":"Mitochondrial dysfunction in autism","volume":"304","author":"Giulivi","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0625","doi-asserted-by":"crossref","first-page":"e1405","DOI":"10.1542\/peds.2013-1545","article-title":"Deficits in bioenergetics and impaired immune response in granulocytes from children with autism","volume":"133","author":"Napoli","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0630","doi-asserted-by":"crossref","first-page":"e134","DOI":"10.1038\/tp.2012.61","article-title":"Evidence of oxidative damage and inflammation associated with low glutathione redox status in the autism brain","volume":"2","author":"Rose","year":"2012","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0635","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1471-4159.2011.07189.x","article-title":"Brain region-specific deficit in mitochondrial electron transport chain complexes in children with autism","volume":"117","author":"Chauhan","year":"2011","journal-title":"J Neurochem"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0640","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.nbd.2013.01.006","article-title":"Mitochondrial abnormalities in temporal lobe of autistic brain","volume":"54","author":"Tang","year":"2013","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0645","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/2040-2392-3-12","article-title":"Brain region-specific altered expression and association of mitochondria-related genes in autism","volume":"3","author":"Anitha","year":"2012","journal-title":"Mol Autism"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0650","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/bpa.12002","article-title":"Downregulation of the expression of mitochondrial electron transport complex genes in autism brains","volume":"23","author":"Anitha","year":"2013","journal-title":"Brain Pathol"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0655","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3389\/fphys.2014.00150","article-title":"Evidence linking oxidative stress, mitochondrial dysfunction, and inflammation in the brain of individuals with autism","volume":"5","author":"Rossignol","year":"2014","journal-title":"Front Physiol"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0660","doi-asserted-by":"crossref","first-page":"5033","DOI":"10.1128\/MCB.01665-05","article-title":"Gene expression analysis exposes mitochondrial abnormalities in a mouse model of Rett syndrome","volume":"26","author":"Kriaucionis","year":"2006","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0665","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1177\/088307380001500601","article-title":"Autism associated with the mitochondrial DNA G8363A transfer RNA(Lys) mutation","volume":"15","author":"Graf","year":"2000","journal-title":"J Child Neurol"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0670","doi-asserted-by":"crossref","first-page":"e85436","DOI":"10.1371\/journal.pone.0085436","article-title":"Oxidative stress induces mitochondrial dysfunction in a subset of autism lymphoblastoid cell lines in a well-matched case control cohort","volume":"9","author":"Rose","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0675","doi-asserted-by":"crossref","first-page":"e377","DOI":"10.1038\/tp.2014.15","article-title":"Oxidative stress induces mitochondrial dysfunction in a subset of autistic lymphoblastoid cell lines","volume":"4","author":"Rose","year":"2014","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0680","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/0006-3223(93)90017-8","article-title":"A preliminary 31P MRS study of autism: evidence for undersynthesis and increased degradation of brain membranes","volume":"33","author":"Minshew","year":"1993","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0685","first-page":"179","article-title":"Polyunsaturated fatty acids, carnitine and lactate as biological markers of brain energy in autistic children","volume":"2","author":"Mostafa","year":"2005","journal-title":"Int J Child Neuropsychiatry"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0690","doi-asserted-by":"crossref","first-page":"e273","DOI":"10.1038\/tp.2013.51","article-title":"Redox metabolism abnormalities in autistic children associated with mitochondrial disease","volume":"3","author":"Frye","year":"2013","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0695","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1177\/088307380201700607","article-title":"Mitochondrial dysfunction in patients with hypotonia, epilepsy, autism, and developmental delay: HEADD syndrome","volume":"17","author":"Fillano","year":"2002","journal-title":"J Child Neurol"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0700","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/ana.10596","article-title":"Mitochondrial dysfunction in autistic patients with 15q inverted duplication","volume":"53","author":"Filipek","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0705","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1177\/08830738060210021401","article-title":"Developmental regression and mitochondrial dysfunction in a child with autism","volume":"21","author":"Poling","year":"2006","journal-title":"J Child Neurol"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0710","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.nbd.2012.06.007","article-title":"Oxidative burden and mitochondrial dysfunction in a mouse model of Rett syndrome","volume":"48","author":"Grosser","year":"2012","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0715","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1471-2202-11-53","article-title":"Downstream targets of methyl CpG binding protein 2 and their abnormal expression in the frontal cortex of the human Rett syndrome brain","volume":"11","author":"Gibson","year":"2010","journal-title":"BMC Neurosci"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0720","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1177\/0883073809342004","article-title":"Acquired microcephaly, regression of milestones, mitochondrial dysfunction, and episodic rigidity in a 46, XY male with a de novo MECP2 gene mutation","volume":"25","author":"Condie","year":"2010","journal-title":"J Child Neurol"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0725","doi-asserted-by":"crossref","first-page":"e42504","DOI":"10.1371\/journal.pone.0042504","article-title":"Mitochondrial dysfunction in Pten haplo-insufficient mice with social deficits and repetitive behavior: interplay between Pten and p53","volume":"7","author":"Napoli","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0730","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1177\/0883073811429858","article-title":"Mitochondrial disease in 22q13 duplication syndrome","volume":"27","author":"Frye","year":"2012","journal-title":"J Child Neurol"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0735","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1177\/0883073809333531","article-title":"15q11.2-13 duplication, mitochondrial dysfunction, and developmental disorders","volume":"24","author":"Frye","year":"2009","journal-title":"J Child Neurol"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0740","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.neulet.2009.06.079","article-title":"Mitochondrial dysfunction in CA1 hippocampal neurons of the UBE3A deficient mouse model for Angelman syndrome","volume":"487","author":"Su","year":"2011","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0745","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/ana.10151","article-title":"Septo-optic dysplasia associated with a new mitochondrial cytochrome b mutation","volume":"51","author":"Schuelke","year":"2002","journal-title":"Ann Neurol"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0750","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/978-1-4614-0653-2_22","article-title":"Oxidative stress and mitochondrial dysfunction in Down syndrome","volume":"724","author":"Pagano","year":"2012","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0755","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s10522-010-9269-4","article-title":"Mitochondrial dysfunction in some oxidative stress-related genetic diseases: ataxia\u2013telangiectasia, Down syndrome, Fanconi anaemia and Werner syndrome","volume":"11","author":"Pallardo","year":"2010","journal-title":"Biogerontology"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0760","doi-asserted-by":"crossref","first-page":"e76993","DOI":"10.1371\/journal.pone.0076993","article-title":"Fecal microbiota and metabolome of children with autism and pervasive developmental disorder not otherwise specified","volume":"8","author":"De Angelis","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0765","doi-asserted-by":"crossref","first-page":"52","DOI":"10.7453\/gahmj.2013.089","article-title":"Autism: metabolism, mitochondria, and the microbiome","volume":"2","author":"Macfabe","year":"2013","journal-title":"Glob Adv Health Med"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0770","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0165-0173(00)00038-2","article-title":"CNS energy metabolism as related to function","volume":"34","author":"Ames","year":"2000","journal-title":"Brain Res Brain Res Rev"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0775","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1385\/NMM:2:2:215","article-title":"Energetics and oxidative stress in synaptic plasticity and neurodegenerative disorders","volume":"2","author":"Mattson","year":"2002","journal-title":"Neuromolecular Med"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0780","doi-asserted-by":"crossref","first-page":"R169","DOI":"10.1093\/hmg\/ddp326","article-title":"Mitochondrial dynamics\u2014fusion, fission, movement, and mitophagy\u2014in neurodegenerative diseases","volume":"18","author":"Chen","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0785","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.cell.2004.11.003","article-title":"The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses","volume":"119","author":"Li","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0790","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3844\/ajbbsp.2008.167.176","article-title":"Bridging from cells to cognition in autism pathophysiology: biological pathways to defective brain function and plasticity","volume":"4","author":"Anderson","year":"2008","journal-title":"Am J Biochem Biotechnol"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0795","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.biopsych.2006.12.029","article-title":"Excess of high frequency electroencephalogram oscillations in boys with autism","volume":"62","author":"Orekhova","year":"2007","journal-title":"Biol Psychiatry"},{"issue":"Suppl. 1","key":"10.1016\/j.yebeh.2014.08.134_bb0800","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1016\/j.expneurol.2004.03.027","article-title":"Development of neurotransmitter systems during critical periods","volume":"190","author":"Herlenius","year":"2004","journal-title":"Exp Neurol"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0805","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z","article-title":"Regional differences in synaptogenesis in human cerebral cortex","volume":"387","author":"Huttenlocher","year":"1997","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0810","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.ijdevneu.2010.06.004","article-title":"Developmental changes in cerebral grey and white matter volume from infancy to adulthood","volume":"28","author":"Groeschel","year":"2010","journal-title":"Int J Dev Neurosci"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0815","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.neuint.2012.02.013","article-title":"Glutamate and GABA synthesis, release, transport and metabolism as targets for seizure control","volume":"61","author":"Rowley","year":"2012","journal-title":"Neurochem Int"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0820","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S1734-1140(13)71060-0","article-title":"Research advances in basic mechanisms of seizures and antiepileptic drug action","volume":"65","author":"Lason","year":"2013","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0825","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0009-8981(03)00200-6","article-title":"Analysis of glutathione: implication in redox and detoxification","volume":"333","author":"Pastore","year":"2003","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0830","doi-asserted-by":"crossref","first-page":"795259","DOI":"10.1155\/2012\/795259","article-title":"Oxidative stress and epilepsy: literature review","volume":"2012","author":"Aguiar","year":"2012","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0835","doi-asserted-by":"crossref","first-page":"4694","DOI":"10.2174\/09298673113209990155","article-title":"The use of flavonoids in central nervous system disorders","volume":"20","author":"Grosso","year":"2013","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0840","doi-asserted-by":"crossref","first-page":"994","DOI":"10.2174\/156802612800229224","article-title":"Targeting oxidative stress component in the therapeutics of epilepsy","volume":"12","author":"Azam","year":"2012","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0845","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.eplepsyres.2011.09.021","article-title":"Modulation of oxidative stress and mitochondrial function by the ketogenic diet","volume":"100","author":"Milder","year":"2012","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0850","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.eplepsyres.2011.09.022","article-title":"The ketogenic diet for the treatment of glioma: insights from genetic profiling","volume":"100","author":"Scheck","year":"2012","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0855","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3389\/fncel.2013.00195","article-title":"Immune mechanisms in epileptogenesis","volume":"7","author":"Xu","year":"2013","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0860","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2013.05.005","article-title":"Immunological and autoimmune considerations of autism spectrum disorders","volume":"44","author":"Gesundheit","year":"2013","journal-title":"J Autoimmun"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0865","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0022-3476(99)70248-9","article-title":"Serum autoantibodies to brain in Landau\u2013Kleffner variant, autism, and other neurologic disorders","volume":"134","author":"Connolly","year":"1999","journal-title":"J Pediatr"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0870","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.biopsych.2005.07.004","article-title":"Brain-derived neurotrophic factor and autoantibodies to neural antigens in sera of children with autistic spectrum disorders, Landau\u2013Kleffner syndrome, and epilepsy","volume":"59","author":"Connolly","year":"2006","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0875","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nature10907","article-title":"Wild-type microglia arrest pathology in a mouse model of Rett syndrome","volume":"484","author":"Derecki","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0880","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nrn1428","article-title":"Immune signalling in neural development, synaptic plasticity and disease","volume":"5","author":"Boulanger","year":"2004","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0885","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1749-6632.2008.03572.x","article-title":"Genetic calcium signaling abnormalities in the central nervous system: seizures, migraine, and autism","volume":"1151","author":"Gargus","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0890","first-page":"4","article-title":"Channelopathy pathogenesis in autism spectrum disorders","author":"Schmunk","year":"2013","journal-title":"Front Genet"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0895","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.cell.2004.09.011","article-title":"Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism","volume":"119","author":"Splawski","year":"2004","journal-title":"Cell"},{"issue":"Pt 1","key":"10.1016\/j.yebeh.2014.08.134_bb0900","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1469-7793.2000.00037.x","article-title":"Mitochondria as all-round players of the calcium game","volume":"529","author":"Rizzuto","year":"2000","journal-title":"J Physiol"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0905","first-page":"2233","article-title":"Calcium trafficking integrates endoplasmic reticulum function with mitochondrial bioenergetics","volume":"2014","author":"Kaufman","year":"1843","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0910","first-page":"2253","article-title":"New functions of mitochondria associated membranes in cellular signaling","volume":"2014","author":"van Vliet","year":"1843","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0915","doi-asserted-by":"crossref","first-page":"I15","DOI":"10.12659\/MSM.881792","article-title":"A prospective double-blind, randomized clinical trial of levocarnitine to treat autism spectrum disorders","volume":"17","author":"Geier","year":"2011","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0920","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.rasd.2012.07.006","article-title":"l-Carnitine supplementation improves the behavioral symptoms in autistic children","volume":"7","author":"Fahmy","year":"2013","journal-title":"Res Autism Spectr Disord"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0925","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.plefa.2009.06.003","article-title":"Novel plasma phospholipid biomarkers of autism: mitochondrial dysfunction as a putative causative mechanism","volume":"81","author":"Pastural","year":"2009","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0930","first-page":"A98","article-title":"Familial autism with primary carnitine deficiency, sudden death, hypotonia and hypochromic anemia","volume":"61","author":"Gargus","year":"1997","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0935","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3844\/ajbbsp.2008.198.207","article-title":"Mitochondrial energy-deficient endophenotype in autism","volume":"4","author":"Gargus","year":"2008","journal-title":"Am J Biochem Biotech"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0940","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1177\/0883073809361165","article-title":"5q14.3 deletion manifesting as mitochondrial disease and autism: case report","volume":"25","author":"Ezugha","year":"2010","journal-title":"J Child Neurol"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0945","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1089\/acm.2004.10.1033","article-title":"Pilot study of a moderate dose multivitamin\/mineral supplement for children with autistic spectrum disorder","volume":"10","author":"Adams","year":"2004","journal-title":"J Altern Complement Med"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0950","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/1471-2431-11-111","article-title":"Effect of a vitamin\/mineral supplement on children and adults with autism","volume":"11","author":"Adams","year":"2011","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0955","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/0278-5846(93)90058-Z","article-title":"A preliminary trial of ascorbic acid as supplemental therapy for autism","volume":"17","author":"Dolske","year":"1993","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0960","first-page":"609705","article-title":"Effectiveness of methylcobalamin and folinic acid treatment on adaptive behavior in children with autistic disorder is related to glutathione redox status","volume":"2013","author":"Frye","year":"2013","journal-title":"Autism Res Treat"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0965","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3945\/ajcn.2008.26615","article-title":"Efficacy of methylcobalamin and folinic acid treatment on glutathione redox status in children with autism","volume":"89","author":"James","year":"2009","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0970","first-page":"64","article-title":"A preliminary study of methylcobalamin therapy in autism","volume":"75","author":"Nakano","year":"2005","journal-title":"J Tokyo Women's Med Univ"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0975","first-page":"985","article-title":"N-acetylcysteine for treatment of autism, a case report","volume":"17","author":"Ghanizadeh","year":"2012","journal-title":"J Res Med Sci"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0980","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/1471-244X-13-196","article-title":"A randomized double blind placebo controlled clinical trial of N-acetylcysteine added to risperidone for treating autistic disorders","volume":"13","author":"Ghanizadeh","year":"2013","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0985","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.biopsych.2012.01.014","article-title":"A randomized controlled pilot trial of oral N-acetylcysteine in children with autism","volume":"71","author":"Hardan","year":"2012","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0990","doi-asserted-by":"crossref","first-page":"798957","DOI":"10.1155\/2014\/798957","article-title":"Ubiquinol improves symptoms in children with autism","volume":"2014","author":"Gvozdjakova","year":"2014","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.yebeh.2014.08.134_bb0995","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1177\/08830738020170111501","article-title":"Double-blind, placebo-controlled study of l-carnosine supplementation in children with autistic spectrum disorders","volume":"17","author":"Chez","year":"2002","journal-title":"J Child Neurol"},{"key":"10.1016\/j.yebeh.2014.08.134_bb1000","doi-asserted-by":"crossref","first-page":"e87072","DOI":"10.1371\/journal.pone.0087072","article-title":"Pre- and neonatal exposure to lipopolysaccharide or the enteric metabolite, propionic acid, alters development and behavior in adolescent rats in a sexually dimorphic manner","volume":"9","author":"Foley","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.yebeh.2014.08.134_bb1005","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ijdevneu.2014.04.001","article-title":"Sexually dimorphic effects of prenatal exposure to propionic acid and lipopolysaccharide on social behavior in neonatal, adolescent, and adult rats: implications for autism spectrum disorders","volume":"39","author":"Foley","year":"2014","journal-title":"Int J Dev Neurosci"},{"key":"10.1016\/j.yebeh.2014.08.134_bb1010","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1159\/000362645","article-title":"The ketogenic diet modifies social and metabolic alterations identified in the prenatal valproic acid model of autism spectrum disorder","volume":"36","author":"Ahn","year":"2014","journal-title":"Dev Neurosci"},{"issue":"Suppl. 8","key":"10.1016\/j.yebeh.2014.08.134_bb1015","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1528-1167.2008.01851.x","article-title":"A new rat model for vulnerability to epilepsy and autism spectrum disorders","volume":"49","author":"Gilby","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2014.08.134_bb1020","doi-asserted-by":"crossref","first-page":"e65021","DOI":"10.1371\/journal.pone.0065021","article-title":"Ketogenic diet improves core symptoms of autism in BTBR mice","volume":"8","author":"Ruskin","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.yebeh.2014.08.134_bb1025","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.eplepsyres.2014.05.010","article-title":"Glucose reduces the anticonvulsant effects of the ketogenic diet in EL mice","volume":"108","author":"Mantis","year":"2014","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2014.08.134_bb1030","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/BF01799112","article-title":"Clinical presentation of mitochondrial disorders in childhood","volume":"19","author":"Munnich","year":"1996","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.yebeh.2014.08.134_bb1035","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1177\/088307380001500110","article-title":"Neurologic presentations of mitochondrial disorders","volume":"15","author":"Nissenkorn","year":"2000","journal-title":"J Child Neurol"},{"key":"10.1016\/j.yebeh.2014.08.134_bb1040","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1093\/brain\/awh259","article-title":"Mitochondrial disorders","volume":"127","author":"Zeviani","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.yebeh.2014.08.134_bb1045","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.pathophys.2006.05.007","article-title":"Oxidative stress in autism","volume":"13","author":"Chauhan","year":"2006","journal-title":"Pathophysiology"},{"key":"10.1016\/j.yebeh.2014.08.134_bb1050","doi-asserted-by":"crossref","first-page":"e360","DOI":"10.1038\/tp.2014.4","article-title":"Environmental toxicants and autism spectrum disorders: a systematic review","volume":"4","author":"Rossignol","year":"2014","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.yebeh.2014.08.134_bb1055","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1177\/088307380001500701","article-title":"Short-term benefit from oral vancomycin treatment of regressive-onset autism","volume":"15","author":"Sandler","year":"2000","journal-title":"J Child Neurol"},{"key":"10.1016\/j.yebeh.2014.08.134_bb1060","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1086\/341914","article-title":"Gastrointestinal microflora studies in late-onset autism","volume":"35","author":"Finegold","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.yebeh.2014.08.134_bb1065","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1212\/01.wnl.0000244435.27645.54","article-title":"Mitochondrial disease criteria: diagnostic applications in children","volume":"67","author":"Morava","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2014.08.134_bb1070","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1023\/A:1024489218004","article-title":"Mitochondrial disorders: clinical presentation and diagnostic dilemmas","volume":"26","author":"Smeitink","year":"2003","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.yebeh.2014.08.134_bb1075","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1055\/s-2007-991148","article-title":"Folate receptor autoantibodies and spinal fluid 5-methyltetrahydrofolate deficiency in Rett syndrome","volume":"38","author":"Ramaekers","year":"2007","journal-title":"Neuropediatrics"}],"container-title":["Epilepsy &amp; Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505014004120?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505014004120?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T07:26:10Z","timestamp":1650525970000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505014004120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":215,"alternative-id":["S1525505014004120"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2014.08.134","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic and mitochondrial disorders associated with epilepsy in children with autism spectrum disorder","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2014.08.134","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Author. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}